Conference Overview

The Premier Destination for Cardiometabolic Innovation

The Annual Cardiometabolic Health Congress made its return to Boston in 2022 and was a huge success! Register now to access the On Demand recordings and join the foremost leaders in cardiometabolic medicine for an actionable examination on the latest research and updates in the field.

17th Annual
Cardiometabolic Health
Congress

Play Video

CMHC Faculty

CMHC Chairpersons
Senior Planning Committee
Faculty

On Demand  Agenda

2022 CMHC On Demand
Cardiometabolic Health in Older Adults: Gaps, Best Practices and Expert Perspectives
Opening Remarks

Robert H. Eckel, MD
Healthy Aging and Cardiometabolic Risk: Overview and Perspectives

Donald M. Lloyd-Jones, MD
Assessing Frailty in Clinical Practice

Jeff D. Williamson, MD
Maintaining a Healthy Lifestyle in Older Adults: Recommendations to Improve Nutrition and Physical Activity

Dennis T. Villareal, MD
Older Adults and Hypertension: Beyond the Guidelines

Dena Rifkin, MD
Lipid Lowering Therapy in Older Adults: Guidelines, Gaps, and Emerging Options

Kenneth Feingold, MD
Deprescribing in Older Adults with Type 2 Diabetes: Strategies and Perspectives

Marie E. McDonnell, MD
Polypharmacy and Drug-Drug Interactions in Older Adults with Cardiovascular Disease

Joseph Saseen, PharmD
Expert Panel Discussion and Audience Q&A

Moderator: Robert H. Eckel, MD

Panelists: Kenneth Feingold, MD; Donald Lloyd-Jones, MD; Dena Rifkin, MD; Jeff D. Williamson, MD; Marie E. McDonnell, MD; Dennis T. Villareal, MD  
FDA Update and Late Breaking Trials and Keynote
Opening Remarks & FDA Update and Late Breaking Trials
Chair: Christie M. Ballantyne, MD
Presenters: Robert H. Eckel, MD; Anne L. Peters, MD; George L. Bakris, MD;Keith C. Ferdinand, MD; Deepak L. Bhatt, MD, MPH
Keynote Address: Therapeutic Inertia in Cardiometabolic Disease
Louis Philipson, MD, PhD
Obesity & Lifestyle
Opening Remarks

Robert H. Eckel, MD
Physical Activity & Cardiometabolic Health: Benefits and Perspectives

Jill Kanaley, PhD
Healthy Eating Patterns: Updates from Recent Guidelines

Amy Hess-Fischl, MS, RD, LDN, BC-ADM, CDCES
Pre-Obesity: Intervening Early to Decrease Future Complications

Michelle Look, MD
Dispelling Common Myths About Obesity

Fatima Cody Stanford, MD, MPH, MPA, MBA, FAAP, FACP, FAHA, FAMWA, FTOS
Making Sense of the Evolving Treatment Landscape in Obesity

Louis J. Aronne, MD
 Challenging Obesity Cases & Panel Discussion
Moderator: Robert H. Eckel, MD
Panelists: Louis J. Aronne, MD; Jill Kanaley, PhD; Michelle Look, MD; Fatima Cody Stanford, MD, MPH, MPA, MBA, FAAP, FACP, FAHA, FAMWA, FTOS; Amy Hess-Fischl, MS, RD, LDN, BC-ADM, CDCES
Opening Remarks & FDA Update and Late Breaking Trials
Chair: Christie M. Ballantyne, MD
Presenters: Robert H. Eckel, MD; Anne L. Peters, MD; George L. Bakris, MD;Keith C. Ferdinand, MD; Deepak L. Bhatt, MD, MPH
Keynote Address: Therapeutic Inertia in Cardiometabolic Disease

Louis Philipson, MD, PhD
Dyslipidemia/Atherosclerosis/Thrombosis
Opening Remarks

Christie M. Ballantyne, MD
The Role of Imaging Modalities in Atherosclerosis & Cardiovascular Risk Stratification

Michael Blaha, MD
Defining and Quantifying Residual ASCVD Risk in 2022

Erin D. Michos, MD
The Evolving Story of Lipoprotein (a)

Patrick Moriarty, MD
 The Changing Treatment Landscape in Dysplipidemia: New and Emerging Agents

Pam R. Taub, MD
Challenging Lipid Management Cases & Panel Discussion

Moderator: Christie M. Ballantyne, MD

Panelists: Michael Blaha, MD; Robert H. Eckel, MD; Pam R. Taub, MD; Patrick Moriarty, MD; Erin D. Michos, MD
Diabetes Management
Opening Remarks

Anne L. Peters, MD
Nutrition and Diets in Diabetes: Quantity vs. Quality

Alison B. Evert, MS, RDN, CDCES
Why Should We Use CGM in Patients with Type 2 Diabetes? Assessing the Evidence and Practical Pearls for Integration

Supported by an educational grant from Dexcom.
Irl B. Hirsch, MD
Emerging Treatment Options for Diabetes

Juan P. Frias, MD
 Challenges with Insulin Management for Diabetes

Irl B. Hirsch, MD
Challenging Diabetes Management Cases & Panel Discussion

Moderator: Anne L. Peters, MD

Panelists: Juan P. Frias, MD; Vanita R. Aroda, MD; Irl B. Hirsch, MD; Alison B. Evert, MS, RDN, CDCES
CardioRenal
Opening Remarks

George L. Bakris, MD
Update of Cardiorenal Risk Reduction: The advent of Pillar Therapy in Kidney Disease

George L. Bakris, MD
Challenges and Advances in Heart Failure Management: How to Individualize Therapy Accordingly

Alanna A. Morris, MD
Novel and Emerging Therapies in Heart Failure

Ileana L Piña, MD
Non-Steroidal MRAs: DKD and Beyond

Rajiv Agarwal, MD
Importance of Assessment and Potential Treatment of Masked Hypertension

Raymond R. Townsend, MD
Therapeutic Inertia and Resistant Hypertension: Strategies to Achieve Treatment Goals
Brent Egan, MD
Challenging Cardiorenal Cases & Expert Panel Discussion
Moderator: George L. Bakris, MD
Panel: Rajiv Agarwal, MD; Brent Egan, MD; Alanna A. Morris, MD; Ileana L Piña, MD; Raymond R. Townsend, MD
2022 CMHC On Demand
1
Cardiometabolic Health in Older Adults: Gaps, Best Practices and Expert Perspectives

Opening Remarks
Robert H. Eckel, MD

Healthy Aging and Cardiometabolic Risk: Overview and Perspectives
Donald M. Lloyd-Jones, MD

Assessing Frailty in Clinical Practice
Jeff D. Williamson, MD

Maintaining a Healthy Lifestyle in Older Adults: Recommendations to Improve Nutrition and Physical Activity
Dennis T. Villareal, MD

Older Adults and Hypertension: Beyond the Guidelines
Dena Rifkin, MD

Lipid Lowering Therapy in Older Adults: Guidelines, Gaps, and Emerging Options
Kenneth Feingold, MD

Deprescribing in Older Adults with Type 2 Diabetes: Strategies and Perspectives
Marie E. McDonnell, MD

Polypharmacy and Drug-Drug Interactions in Older Adults with Cardiovascular
Joseph Saseen, PharmD

Expert Panel Discussion and Audience Q&A
Moderator: Robert H. Eckel, MD
Panelists: Kenneth Feingold, MD; Donald Lloyd-Jones, MD; Dena Rifkin, MD; Jeff D. Williamson, MD; Marie E. McDonnell, MD; Dennis T. Villareal, MD
2
FDA Update and Late Breaking Trials and Keynote
Opening Remarks & FDA Update and Late Breaking Trials Chair: Christie M. Ballantyne Presenters: Robert H. Eckel, MD; Anne L. Peters, MD; George L. Bakris, MD; Keith C. Ferdinand, MD; Deepak L. Bhatt, MD, MPH
Keynote Address: Therapeutic Inertia in Cardiometabolic Disease Louis Philipson, MD, PhD
3
Obesity & Lifestyle

Opening Remarks
Robert H. Eckel, MD

Physical Activity & Cardiometabolic Health: Benefits and Perspectives
Jill Kanaley, PhD

Healthy Eating Patterns: Updates from Recent Guidelines
Amy Hess-Fischl, MS, RD, LDN, BC-ADM, CDCES

Pre-Obesity: Intervening Early to Decrease Future Complications
Michelle Look, MD

Dispelling Common Myths About Obesity
Fatima Cody Stanford, MD, MPH, MPA, MBA, FAAP, FACP, FAHA, FAMWA, FTOS

Making Sense of the Evolving Treatment Landscape in Obesity
Louis J. Aronne, MD

Challenging Obesity Cases & Panel Discussion
Moderator: Robert H. Eckel, MD
Panelists: Louis J. Aronne, MD; Jill Kanaley, PhD; Michelle Look, MD; Fatima Cody Stanford, MD, MPH, MPA, MBA, FAAP, FACP, FAHA, FAMWA, FTOS; Amy Hess-Fischl, MS, RD, LDN, BC-ADM, CDCES
4
Dyslipidemia/Atherosclerosis/Thrombosis

Opening Remarks
Christie M. Ballantyne, MD

The Role of Imaging Modalities in Atherosclerosis & Cardiovascular Risk Stratification
Michael Blaha, MD

Defining and Quantifying Residual ASCVD Risk in 2022
Erin D. Michos, MD

The Evolving Story of Lipoprotein (a)
Patrick Moriarty, MD

The Changing Treatment Landscape in Dysplipidemia: New and Emerging Agents
Pam R. Taub, MD

Challenging Lipid Management Cases & Panel Discussion
Moderator: Christie M. Ballantyne, MD
Panelists: Michael Blaha, MD; Robert H. Eckel, MD; Pam R. Taub, MD; Patrick Moriarty, MD; Erin D. Michos, MD
5
Diabetes Management

Opening Remarks
Anne L. Peters, MD

Nutrition and Diets in Diabetes: Quantity vs. Quality
Alison B. Evert, MS, RDN, CDCES

Why Should We Use CGM in Patients with Type 2 Diabetes? Assessing the Evidence and Practical Pearls for Integration
Supported by an educational grant from Dexcom.
Irl B.Hirsch, MD

Emerging Treatment Options for Diabetes
Juan P. Frias, MD

Challenges with Insulin Management for Diabetes
Irl B. Hirsch, MD

Challenging Diabetes Management Cases & Panel Discussion
Moderator: Anne L. Peters, MD
Panelists: Juan P. Frias, MD; Vanita R. Aroda, MD; Irl B. Hirsch, MD; Alison B. Evert, MS, RDN, CDCES

6
CardioRenal


Opening Remarks
George L. Bakris, MD

Update of Cardiorenal Risk Reduction: The advent of Pillar Therapy in Kidney Disease
George L. Bakris, MD

Challenges and Advances in Heart Failure Management: How to Individualize Therapy Accordingly
Alanna A. Morris, MD

Novel and Emerging Therapies in Heart Failure
Ileana L Piña, MD

Non-Steroidal MRAs: DKD and Beyond
Rajiv Agarwal, MD

Importance of Assessment and Potential Treatment of Masked Hypertension
Raymond R. Townsend, MD

Therapeutic Inertia and Resistant Hypertension: Strategies to Achieve Treatment Goals
Brent Egan, MD

Challenging Cardiorenal Cases & Expert Panel Discussion
Moderator: George L. Bakris, MD
Panelists: Rajiv Agarwal, MD; Brent Egan, MD; Alanna A. Morris, MD; Ileana L Piña, MD; Raymond R. Townsend, MD

On Demand  Registration

REGISTER
ACCESS NOW

Thank you to all of our 2022 sponsors and media/association partners!

Thank you to all of our 2022 sponsors and media/association partners!